# GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

> **NCT00105079** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 337 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** saquinavir [Invirase]
- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Emtricitabine/tenofovir disoproxil fumarate
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00105079
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-08
- **Final completion:** 2008-07
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00105079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00105079, "GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00105079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*